VANECK VECTORS BIOTECH ETF
VANECK VECTORS BIOTECH ETF
ETF · US92189F7261 · BBH (FUND)
Overview
154,57 USD
-0,17 % -0,26 USD
Fondsgesellschaft (XNAS) · Current prices and charts at MoneyPeak
11.06.2025 19:59

Current Prices from VANECK VECTORS BIOTECH ETF

ExchangeTickerCurrencyLast TradePriceDaily Change
XNAS: NASDAQ
NASDAQ
BBH
USD
11.06.2025 19:59
154,57 USD
154,83 USD
-0,17 %

Performance

Day Week Month 3 Months 6 Months 1 Year 5 Years
0,00 % 2,70 % 10,16 % -5,05 % -7,01 % -7,64 % 0,66 %
Asset Allocation
AssetPercentage %
Stock US88,48 %
Stock non-US11,35 %
Cash0,16 %
NotClassified0,00 %
Other0,00 %
Bond0,00 %
Largest Positions
SymbolISINNamePercentage %
MRNAModerna Inc 9,68 %
AMGNAmgen Inc 8,28 %
REGNRegeneron Pharmaceuticals Inc 6,27 %
BNTXBioNTech SE 6,17 %
GILDGilead Sciences Inc 5,77 %
ILMNIllumina Inc 5,41 %
CRLCharles River Laboratories International Inc 5,39 %
IQVIQVIA Holdings Inc 5,35 %
SGENSeagen Inc 4,57 %
VRTXVertex Pharmaceuticals Incorporated 4,56 %
Region Distribution
RegionPercentage %
North America88,63 %
Europe Developed8,56 %
Asia Emerging2,81 %
Africa/Middle East0,00 %
Asia Developed0,00 %
Australasia0,00 %
Europe Emerging0,00 %
Japan0,00 %
Latin America0,00 %
United Kingdom0,00 %
Sector Distribution
SectorPercentage %
Gesundheitswesen100,00 %
Grundstoffe0,00 %
Verbrauchsgüter0,00 %
Finanzdienstleistungen0,00 %
Immobilien0,00 %
Telekommunikation0,00 %
Energie0,00 %
Industrieunternehmen0,00 %
Technologie0,00 %
Basiskonsumgüter0,00 %

Company Profile for VANECK VECTORS BIOTECH ETF ETF

The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.
Fund Master Data
Issuer VanEck
Asset Class ETF
Name VanEck Vectors Biotech ETF
Fund Currency USD
Category Health
Payout NA
fund.
Morningstar Rating 3
Fund Key Figures
Fund Size 574.355,84 EUR
Investment Strategy
The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the MVIS® US Listed Biotech 25 Index. The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Biotech Index includes common stocks and depositary receipts of U.S. exchange-listed companies in the biotechnology industry. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

Company Data

Name VANECK VECTORS BIOTECH ETF
Company VanEck Biotech ETF
Symbol BBH
Primary Exchange FUND Fondsgesellschaft
ISIN US92189F7261
Asset Class ETF
Sector Financial Services
Industry Asset Management
Market Capitalization 365 Mio
Country United States of America
Currency USD
Employees -
IPO Date 1999-11-23
Dividends from 'VANECK VECTORS BIOTECH ETF'
Ex-Date Dividend per Share
23.12.2024 1,25 USD
18.12.2023 0,71 USD
19.12.2022 0,75 USD
20.12.2021 0,40 USD
21.12.2020 0,61 USD
23.12.2019 0,47 USD
20.12.2018 0,55 USD
18.12.2017 0,68 USD
19.12.2016 0,33 USD
21.12.2015 0,34 USD

Ticker Symbols

Name Symbol
NASDAQ BBH

More Shares

Investors who VANECK VECTORS BIOTECH ETF hold also have the following shares in their portfolio:
BRF 19/30 REGS
BRF 19/30 REGS Bond
LBBW GM-FLOATER 13/21
LBBW GM-FLOATER 13/21 Bond
The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.
Imprint Data Protection Blog Community Feedback Changelog
Im App Store herunterladen Bei Google Play herunterladen
All rights reserved © LCP GmbH 2025